These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Effect of diseases on the kinetics of cardiac glycosides and its significance for general practice]. Gilfrich HJ Verh Dtsch Ges Herz Kreislaufforsch; 1982; 48():28-34. PubMed ID: 7187161 [No Abstract] [Full Text] [Related]
3. [Interaction of cardiac glycosides with other drugs]. Greeff K Verh Dtsch Ges Herz Kreislaufforsch; 1982; 48():40-6. PubMed ID: 7187163 [No Abstract] [Full Text] [Related]
4. [Treatment of congestive heart failure with cardiac glycosides. I. New theses in the principles of treatment]. Tomov I Vutr Boles; 1980; 19(6):7-14. PubMed ID: 7210653 [No Abstract] [Full Text] [Related]
5. [Peculiarities of cardiac glycoside therapy in the aged]. Erdmann E Internist (Berl); 1991 Aug; 32(8):472-8. PubMed ID: 1938268 [No Abstract] [Full Text] [Related]
6. [Therapy control in cardiology: serum level monitoring]. Ochs HR Z Kardiol; 1984 Oct; 73(10):605-12. PubMed ID: 6516513 [TBL] [Abstract][Full Text] [Related]
7. [Introduction to clinical pharmacodynamics and pharmacokinetics of cardiac glycosides]. Kudrin AN; Namakanov BA; Davydova ON Sov Med; 1981; (11):70-4. PubMed ID: 7038899 [No Abstract] [Full Text] [Related]
8. [Elimination of cardiac glycosides by hemofiltration]. Kramer P; Matthias C; Matthaei D; Scheler F Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1618-21. PubMed ID: 611892 [No Abstract] [Full Text] [Related]
9. [Pharmacokinetic and biological effective time of beta-receptor blockers in renal insufficiency]. Knauf H; Schäfer-Korting M; Mutschler E Internist (Berl); 1981 Oct; 22(10):616-21. PubMed ID: 6117538 [No Abstract] [Full Text] [Related]
10. [Clinical pharmacology of cardiac glycosides]. Haustein KO Pol Tyg Lek; 1978 May; 33(20):817-20. PubMed ID: 673918 [No Abstract] [Full Text] [Related]
11. [Effective concentration and dosage for cardiac glycosides]. Weiss M; Förster W Z Gesamte Inn Med; 1980 Jan; 35(1):1-7. PubMed ID: 6996345 [TBL] [Abstract][Full Text] [Related]
12. [On the pharmacokinetics of peruvoside. I. Comparative clinical and experimental animal studies]. Hundeshagen H; Zeidler U; Fabel H; Garbe A; Nowak H Arzneimittelforschung; 1968 Dec; 18(12):1592-6. PubMed ID: 5756259 [No Abstract] [Full Text] [Related]
13. Clinical consequences of pharmacokinetic properties of cardiac glycosides. Kochsiek K Eur Heart J; 1982 Dec; 3 Suppl D():79-86. PubMed ID: 6761130 [No Abstract] [Full Text] [Related]
14. [Drug interactions with digitalis glycosides]. Hall D; Kraus F; Rudolph W Herz; 1993 Apr; 18(2):124-34. PubMed ID: 8491441 [No Abstract] [Full Text] [Related]
15. [Significance of glycoside level of the blood]. Kochsiek K Verh Dtsch Ges Herz Kreislaufforsch; 1982; 48():35-9. PubMed ID: 7187162 [No Abstract] [Full Text] [Related]
16. [Therapy of coronary insufficiency with digitalis. 1. Principles of therapy]. Grosse-Brockhoff F Fortschr Med; 1981 Apr; 99(16):573-5. PubMed ID: 7227950 [No Abstract] [Full Text] [Related]
17. [Recent acquisitions in the study of the pharmacology of cardiac glycosides. Pharmacokinetic approach to therapy with cardiac glycosides]. Lesne M J Pharm Belg; 1973; 28(2):217-33. PubMed ID: 4733470 [No Abstract] [Full Text] [Related]
18. [Characteristics of the reaction of the child's body to cardiac glycosides]. Viktorov OP Farm Zh; 1979; (3):12-5. PubMed ID: 378685 [No Abstract] [Full Text] [Related]
19. [Determination of cardiac glycosides in biological media]. Bolanowska W Postepy Hig Med Dosw; 1976; 30(1):133-44. PubMed ID: 1257165 [No Abstract] [Full Text] [Related]
20. Drug absorption in congestive heart failure: impact on management. Sica DA Prog Cardiovasc Nurs; 1999; 14(1):30-2. PubMed ID: 10431317 [No Abstract] [Full Text] [Related] [Next] [New Search]